A Brazilian volunteer participating in trials for
Anvisa didn’t inform whether the participant had received an actual dose of the vaccine or a placebo, the newspapers said. The health regulator didn’t immediately respond to a request for comment.
To contact the reporter on this story:
To contact the editors responsible for this story:
© 2020 Bloomberg L.P. All rights reserved. Used with permission.